Literature DB >> 36053374

Complications of catheter ablation for ventricular tachycardia.

Aishwarya Pastapur1, Daniel McBride2, Amrish Deshmukh2, Stefanie Driesenga2, Michael Ghannam2, Frank Bogun2, Jackson J Liang3.   

Abstract

With the increasing literature demonstrating benefits of catheter ablation for ventricular tachycardia (VT), the number of patients undergoing VT ablation has increased dramatically. As VT ablation is being performed more routinely, operators must be aware of potential complications of VT ablation. This review delves deeper into the practice of VT ablation with a focus on periprocedural complications.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adverse outcome; Catheter ablation; Complication; Injury; Ventricular tachycardia

Year:  2022        PMID： 36053374     DOI： 10.1007/s10840-022-01357-z

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.759


  110 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH.

Authors:  Lorne J Gula; Steve Doucette; Peter Leong-Sit; Anthony S L Tang; Ratika Parkash; Jean-Francois Sarrazin; Bernard Thibault; Vidal Essebag; Stanley K Tung; Marc W Deyell; Jean-Marc Raymond; Chris Lane; Pablo B Nery; George D Veenhuyzen; Damian P Redfearn; Jeffrey S Healey; Jean-Francois Roux; Karen Giddens; John L Sapp
Journal:  J Cardiovasc Electrophysiol       Date:  2018-01-30

3.  Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.

Authors:  Kathryn Coyle; Doug Coyle; Isabelle Nault; Ratika Parkash; Jeffrey S Healey; Christopher J Gray; Martin J Gardner; Laurence D Sterns; Vidal Essebag; Tomasz Hruczkowski; Louis Blier; George A Wells; Anthony S L Tang; William G Stevenson; John L Sapp
Journal:  JACC Clin Electrophysiol       Date:  2018-03-28

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

Review 5.  Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.

Authors:  Ryan T Borne; Paul D Varosy; Frederick A Masoudi
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

6.  Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.

Authors:  Marc W Deyell; Christian Steinberg; Steve Doucette; Ratika Parkash; Isabelle Nault; Chris Gray; Vidal Essebag; Martin Gardner; Laurence D Sterns; Jeff S Healey; Tomasz Hruczkowski; Lena Rivard; Peter Leong-Sit; Pablo B Nery; John L Sapp
Journal:  J Cardiovasc Electrophysiol       Date:  2018-02-01

7.  Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group.

Authors:  H Calkins; A Epstein; D Packer; A M Arria; J Hummel; D M Gilligan; J Trusso; M Carlson; R Luceri; H Kopelman; D Wilber; J M Wharton; W Stevenson
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

8.  Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry.

Authors:  David F Katz; Pamela Peterson; Ryan T Borne; Jarrod Betz; Sana M Al-Khatib; Paul D Varosy; Yongfei Wang; Jonathan C Hsu; Kurt S Hoffmayer; Ryan T Kipp; Carolina Malta Hansen; Mintu P Turakhia; Frederick A Masoudi
Journal:  JACC Clin Electrophysiol       Date:  2016-09-07

Review 9.  Amiodarone: guidelines for use and monitoring.

Authors:  Lyle A Siddoway
Journal:  Am Fam Physician       Date:  2003-12-01       Impact factor: 3.292

10.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

Authors:  John L Sapp; George A Wells; Ratika Parkash; William G Stevenson; Louis Blier; Jean-Francois Sarrazin; Bernard Thibault; Lena Rivard; Lorne Gula; Peter Leong-Sit; Vidal Essebag; Pablo B Nery; Stanley K Tung; Jean-Marc Raymond; Laurence D Sterns; George D Veenhuyzen; Jeff S Healey; Damian Redfearn; Jean-Francois Roux; Anthony S L Tang
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.